FREDUN PHARMACEUTICALS
|
The Current P/E Ratio of FREDUN PHARMACEUTICALS is 38.47.
| Share Price | ₹2,619.7 | Jun 19,2026 |
| Market Cap | ₹1,440.8 Cr | |
| Earnings-TTM | ₹37.5 Cr | TTM-Consolidated Results |
| Price/Earnings | 38.47x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of FREDUN PHARMACEUTICALS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹1,440.8 Cr] as on Jun 19,2026
(/) Earnings [ ₹37.5 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 38.47x ]
Thus, for FREDUN PHARMACEUTICALS , the investors are currently willing to pay 38.47 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of FREDUN PHARMACEUTICALS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of FREDUN PHARMACEUTICALS over the last five years.
Historical PE (Price/Earnings) ratio chart of FREDUN PHARMACEUTICALS
PE Ratio Performance Analysis for FREDUN PHARMACEUTICALS
- FREDUN PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2026 to Mar2025 averaged 22.02x.
- FREDUN PHARMACEUTICALS 's operated at median p/e ratio of 28.05x from fiscal years ending March 2018 to 2022.
- Looking back at the last 2 fiscal years, FREDUN PHARMACEUTICALS 's p/e ratio peaked in Mar2026 at 28.05x.
- FREDUN PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2025 of 15.99x.
How does FREDUN PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| FREDUN PHARMACEUTICALS | 37.45 | 38.47 | 1,440.8 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,564.50 | 38.12 | 440,794.0 |
| DIVIS LABORATORIES LTD | 2,568.00 | 69.69 | 178,956.0 |
| TORRENT PHARMACEUTICALS LTD | 2,138.00 | 70.07 | 149,820.0 |
| CIPLA LTD | 3,869.79 | 28.26 | 109,370.0 |
| DR REDDYS LABORATORIES LTD | 4,144.20 | 25.61 | 106,133.0 |
| MANKIND PHARMA LTD | 1,926.41 | 51.82 | 99,835.6 |
| LUPIN LTD | 5,355.47 | 20.08 | 107,537.0 |
| ZYDUS LIFESCIENCES LTD | 5,026.40 | 21.44 | 107,758.0 |
| AUROBINDO PHARMA LTD | 3,501.45 | 24.61 | 86,183.0 |
| LAURUS LABS LTD | 889.85 | 85.77 | 76,323.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs FREDUN PHARMACEUTICALS 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 20.08x |
| Max industry PE | 85.77x |
| Median industry PE | 38.12x |
| Average industry PE | 43.09x |
You may also like the below Video Courses